400 DAYS WITH NO WORK ACCIDENTS

Main Menu | News By Date | News By Supplier | News By Category | About Us

400 DAYS WITH NO WORK ACCIDENTS
15 September 2004 - NNE A/S

The Kalundborg site in Denmark where Novo Nordisk is building a new insulin factory has not had a single notifiable work accident since construction began last year. An exceptional feat for a construction job of this magnitude, to which more than 200,000 man-hours have already been devoted. Efforts to make the construction site a safe place to work have been ongoing since project start-up. A programme of several new safety courses has played a role in keeping the number of work accidents down.

The Kalundborg site in Denmark where Novo Nordisk is building a new insulin factory has not had a single notifiable work accident since construction began last year.

An exceptional feat for a construction job of this magnitude, to which more than 200,000 man-hours have already been devoted.

Efforts to make the construction site a safe place to work have been ongoing since project start-up. A programme of several new safety courses has played a role in keeping the number of work accidents down.

'Everyone who works at the construction site is required to take a safety course – as well as participating in the daily courses held at the site and updated every quarter. We keep a sharp eye on the site and do not tolerate any infractions of the safety rules. However, we also reward the right behaviour and are always developing new methods to maintain the focus on safety,' says Mikael Larsen, head of safety at NNE.

The new factory is a so-called fast-track project, meaning that the schedule only allows 18 months from construction start to the day the plant is completed and handed over to the client.

The rapid completion requires a constant and cooperative effort of the many contractors, craftsmen and suppliers who employ several hundred people at the site.

'That is why it is crucial for every single employee to understand that safety is a success criterion for Novo Nordisk. We reward good work but also ensure there are consequences for anyone who ignores the safety message,' says Palle Jensen, project manager at Novo Nordisk.

Only three months ago, Novo Nordisk in Kalundborg started construction on another insulin plant for completion in 2005. Last year Novo Nordisk inaugurated the world's largest insulin factory, also at the Kalundborg site.

When all the factories are completed, Novo Nordisk will employ about 2,200 people in the Kalundborg area.

http://nne.dk/

About: NNE A/S
With more than 80 years of experience, the engineering company NNE is a leading supplier of systems, consultancy and engineering services to the international pharmaceutical and biotechnological industry.

Our competencies span all technical disciplines applying to engineering, construction, validation, start-up and optimisation, and reconstruction of facilities for product development and production plants, pilot plants and laboratories within the pharmaceutical and biotechnological field.

Our unmistakable, clear client focus, combined with a flexible and integrated organisation where engineers, architects and pharmacists work closely together, puts us in a position to deliver customised solutions, ranging from stand-alone services to turnkey plants - quickly and safely.

NNE operates at an international level. We have worked on and completed a large number of projects both in Denmark and the rest of Scandinavia, and we have constructed biotechnological and pharmaceutical production facilities in USA, China, Japan, Brazil, and France.

More News:
  • For September 2004
  • From NNE A/S
  • For Medical Equipment